KEGG   DRUG: Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
Entry
D10535                      Drug                                   
Name
Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated;
Menactra (TN);
Nimenrix (TN)
Product
MENACTRA (Sanofi Pasteur), MENVEO (GlaxoSmithKline Biologicals SA)
Remark
ATC code: J07AH08
Product: D10535<US>
Efficacy
Active immunization (pneumococcal)
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J07 VACCINES
   J07A BACTERIAL VACCINES
    J07AH Meningococcal vaccines
     J07AH08 Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
      D10535  Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated <US>
USP drug classification [BR:br08302]
 Immunological Agents
  Vaccines
   Meningococcal
    Meningococcal Polysaccharide (Groups A, C, Y and W-135) Diphtheria Toxoid Conjugate Vaccine (MCV4P)
     D10535  Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10535
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D10535
Other DBs
PubChem: 254741497
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system